<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04359524</url>
  </required_header>
  <id_info>
    <org_study_id>R-002</org_study_id>
    <nct_id>NCT04359524</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation in Conscripts</brief_title>
  <official_title>Fitness and Health Characteristics in Conscripts With Supplementation of Vitamin D</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leho Rips</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Estonian Defence Forces</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tartu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tartu University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A longitudinal, triple-blinded, randomized, placebo-controlled trial, with a 7-month&#xD;
      follow-up period is conducted between October 2016 to April 2017.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Body mass (kg) and height (cm) is measured by the same person at the medical center using&#xD;
      standardized equipment and the body mass index (BMI) is calculated in kg/m2.&#xD;
&#xD;
      Computed randomization is used to divide conscripts into two groups; either the intervention&#xD;
      group or the control group. Both types of capsules are administered once per day in the&#xD;
      morning before breakfast for 7 months. Standardized coded packages (3 per conscript) and&#xD;
      capsules (100 per package) are manufactured on a special order by Innopharma A/S (Denmark).&#xD;
      No commercial sponsoring is involved.&#xD;
&#xD;
      The key of the package code is stored in the computer database until unblinding of the&#xD;
      results.&#xD;
&#xD;
      Laboratory measurements Serum samples for clinical chemistry analysis are collected into&#xD;
      serum clot activator tubes. Calcium measurements are performed using spectrophotometry&#xD;
      method. Ionized calcium measurements are performed using ion selective electrodes. The direct&#xD;
      chemiluminescent immunoassay method is used for measurement of PTH. 25(OH)D is measured using&#xD;
      direct chemiluminescent immunoassay method.&#xD;
&#xD;
      Power calculation The primary variable of the study is the level of 25 (OH)D in the serum. In&#xD;
      the power analysis a difference of 20 nmol/L between the intervention and the control group&#xD;
      is considered to be meaningful to detect. If the SD would be 25 nmol/L, then 26 participants&#xD;
      would be needed in each group to reach a power of 80%.&#xD;
&#xD;
      Statistical analysis The distribution of blood serum values in the study groups is described&#xD;
      by means and standard deviations (SD). Differences in mean values of the variables of&#xD;
      interest between the groups are evaluated using Welch t-test. The within group comparisons&#xD;
      over time are performed using paired t-test with Bonferroni correction. Distributions of&#xD;
      categorical variables are described by absolute numbers and percentages and compared between&#xD;
      groups using the Fisher exact test. Statistical significance is set at the 0.05 probability&#xD;
      level.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2016</start_date>
  <completion_date type="Actual">April 25, 2017</completion_date>
  <primary_completion_date type="Actual">April 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Triple blinded randomized placebo-controlled study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Computed randomization was used to divide conscripts into two groups; either the intervention group, who received vitamin D3 capsules (1200 IU/30µg) or the control group, who received placebo (oil capsules).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of vitamin D deficence</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>Prevalence of vitamin D deficence as measured serum vitamin D 25(OH)D concentration. Vitamin D was considered as sufficient if the se-rum 25(OH)D concentration was ≥75 nmol/L, insufficient if &lt;75 nmol/L, and deficient if &lt;50 nmol/L.</description>
  </primary_outcome>
  <other_outcome>
    <measure>serum parathyroid hormone</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>serum parathyroid hormone concentration (pmol/l)</description>
  </other_outcome>
  <other_outcome>
    <measure>serum calcium</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>serum calcium (Ca) concentration (mmol/l)</description>
  </other_outcome>
  <other_outcome>
    <measure>serum ionized calcium</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>serum ionized calcium (Ca-i) concentration (mmol/l)</description>
  </other_outcome>
  <other_outcome>
    <measure>Hand Grip Strength</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>Hand grip strength is determined by isometric contraction while standing, upper limb away from the body, using a hand dynamometer (Lafayette Instrument Co., USA).</description>
  </other_outcome>
  <other_outcome>
    <measure>Testosterone</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>Serum testosterone concentration (nmol/l)</description>
  </other_outcome>
  <other_outcome>
    <measure>Cortisol</measure>
    <time_frame>0, 2, 5 and 7 months of recruitment</time_frame>
    <description>Serum cortisol concentration (nmol/l)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Military Activity</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Received vitamin D3 capsules (1200 IU/30µg).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Received placebo (oil capsules).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3 (1200 IU/30µg)</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo oil capsule</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  participating in military service at the Estonian Defence Forces&#xD;
&#xD;
          -  voluntarity to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to continue military service for any reason, during the 7 month follow-up&#xD;
             period&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>27 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helena Gapeyeva, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Tartu</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kuperjanov Infantry Battalion, Estonian Defence Forces</name>
      <address>
        <city>Võru</city>
        <state>Võrumaa</state>
        <zip>50400</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 21, 2020</study_first_submitted>
  <study_first_submitted_qc>April 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>September 12, 2021</last_update_submitted>
  <last_update_submitted_qc>September 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tartu University Hospital</investigator_affiliation>
    <investigator_full_name>Leho Rips</investigator_full_name>
    <investigator_title>Head of department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

